Asia-Pacific Leukemia Consortium : An innovative and collaborative initiative to improve care of leukemia and related diseases in the Asia-Pacific region
© 2023 John Wiley & Sons Australia, Ltd..
The burden of leukemia and related diseases is rapidly growing in Asia. Currently, there is a paucity of regional collaborative groups/initiatives that focus exclusively on the management of leukemia in the Asia-Pacific (APAC) region. The Asia-Pacific Leukemia Consortium (APLC) was established on the 8 September 2021 to understand the status quo, unmet needs, and ways to improve the management of leukemia and related diseases in the APAC region. The APLC working group set up a group of experts from various countries (Singapore, Malaysia, Thailand, Hong Kong, Japan, South Korea, Taiwan, China, and Australia) to discuss on the status of: (i) clinical trials; (ii) disease registry database; (iii) genetic and tissue repository; (iv) patient advocacy and care; and (v) disease prevention and education in the APAC region. Low levels of awareness about leukemia amongst the public, lack of financial support, and limited access to newly approved therapies were identified as barriers to the implementation of effective leukemia management in low- or mid-income Asian countries. Patients often enroll in clinical trials to gain access to novel/approved therapies. The APLC group aims to address the growing threat of leukemia through a collaborative approach to advance disease prevention, research, clinical trials, and education.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Asia-Pacific journal of clinical oncology - 19(2023), 6 vom: 08. Dez., Seite 655-663 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lao, Zhentang [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Asia-Pacific |
|---|
| Anmerkungen: |
Date Completed 17.11.2023 Date Revised 17.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/ajco.13970 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357619862 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357619862 | ||
| 003 | DE-627 | ||
| 005 | 20231226073005.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/ajco.13970 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1192.xml |
| 035 | |a (DE-627)NLM357619862 | ||
| 035 | |a (NLM)37259880 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lao, Zhentang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Asia-Pacific Leukemia Consortium |b An innovative and collaborative initiative to improve care of leukemia and related diseases in the Asia-Pacific region |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.11.2023 | ||
| 500 | |a Date Revised 17.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 John Wiley & Sons Australia, Ltd. | ||
| 520 | |a The burden of leukemia and related diseases is rapidly growing in Asia. Currently, there is a paucity of regional collaborative groups/initiatives that focus exclusively on the management of leukemia in the Asia-Pacific (APAC) region. The Asia-Pacific Leukemia Consortium (APLC) was established on the 8 September 2021 to understand the status quo, unmet needs, and ways to improve the management of leukemia and related diseases in the APAC region. The APLC working group set up a group of experts from various countries (Singapore, Malaysia, Thailand, Hong Kong, Japan, South Korea, Taiwan, China, and Australia) to discuss on the status of: (i) clinical trials; (ii) disease registry database; (iii) genetic and tissue repository; (iv) patient advocacy and care; and (v) disease prevention and education in the APAC region. Low levels of awareness about leukemia amongst the public, lack of financial support, and limited access to newly approved therapies were identified as barriers to the implementation of effective leukemia management in low- or mid-income Asian countries. Patients often enroll in clinical trials to gain access to novel/approved therapies. The APLC group aims to address the growing threat of leukemia through a collaborative approach to advance disease prevention, research, clinical trials, and education | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Asia-Pacific | |
| 650 | 4 | |a burden | |
| 650 | 4 | |a collaboration | |
| 650 | 4 | |a leukemia | |
| 650 | 4 | |a status quo | |
| 700 | 1 | |a Tse, Eric Wai Choi |e verfasserin |4 aut | |
| 700 | 1 | |a Chuncharunee, Suporn |e verfasserin |4 aut | |
| 700 | 1 | |a Kwong, Yok Lam |e verfasserin |4 aut | |
| 700 | 1 | |a Wei, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Ko, Bor Sheng |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Jin Seok |e verfasserin |4 aut | |
| 700 | 1 | |a Ng, Soo Chin |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Jianxiang |e verfasserin |4 aut | |
| 700 | 1 | |a Goh, Yeow Tee |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Asia-Pacific journal of clinical oncology |d 2010 |g 19(2023), 6 vom: 08. Dez., Seite 655-663 |w (DE-627)NLM197405231 |x 1743-7563 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2023 |g number:6 |g day:08 |g month:12 |g pages:655-663 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/ajco.13970 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2023 |e 6 |b 08 |c 12 |h 655-663 | ||